Skip to main content
. 2021 Jul 2;21:258. doi: 10.1186/s12883-021-02257-x

Table 1.

Baseline characteristics of participants

Variables Healthy control group (n = 188) Stroke group (n = 216) Stroke risk group (n = 152)
Female gender& 96 (51.1%) 68 (31.5%) 64 (42.1%)
Age$ (year) 73.32 (9.43) 71.76 (9.88) 71.89 (10.22)
BMI$ (kg/m2) 26.55 (4.93) 26.92 (5.85) 27.03 (6.33)
Length of Hospitalization$ (day) ND 11.06 (20.16) ND
NIHSS-baseline ND 8.28 (8.90) ND
NIHSS-follow-up ND 5.11 (4.86) ND
MRS- discharge ND 2.63 (0.78) ND
MRS- follow-up ND 1.78 (1.08) ND
DBP$ (mmHg) 73.62 (9.13) 81.17 (11.92) 87.89 (14.55)
SBP$ (mmHg) 123.09 (14.95) 148.08 (28.02) 150.79 (25.93)
Total cholesterol$ (mg/dl) 167.17 (42.97) 200.06 (62.03) 176.68 (41.58)
Triglyceride$(mg/dl) 119.26 (20.19) 175.20 (91.61) 148.50 (59.29)
LDL$ (mg/dl) 97.81 (26.15) 118.80 (62.58) 111.03 (37.81)
HDL$ (mg/dl) 42.18 (9.31) 46.10 (12.66) 43.36 (13.09)
Serum TAC$ (μmol/L) 3905.98 (879.89) 3687.35 (801.56) 3909.29 (983.87)
Serum MDA$ (μmol/L) 1.85 (0.36) 2.08 (0.24) 1.75 (0.41)

Abbreviations: BMI Body Mass Index, DBP Diastolic Blood Pressure, NIHSS National Institutes of Health Stroke Scale, MRS Modified Rankin Scale, SBP Systolic Blood Pressure, LDL Low-Density Lipoprotein, HDL High-Density Lipoprotein, TAC Total Antioxidant Capacity, MDA Malondialdehyde, ND Not Determined

& Gender is presented as number (percent); there was no significant differences between gender of three group based on Chi-square test (P-value = 0.13)

$ These data are presented as mean (standard deviation)